Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Milestone ScientificMLSS -10.47%37 Gross Margin % is 67.23% as of Jun. 2026, which is 5% above its 10-year median of 64.19. GuruFocus rates MLSS with a GF Score™ of 37/100 and a GF Value™ of $0.60 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 804 Medical Devices & Instruments companies, Milestone Scientific ranks better than 80.35% on this metric.
The historical rank and industry rank for Milestone Scientific's Gross Margin % or its related term are showing as below:
MLSS'
s Gross Margin % Range Over the Past 10 Years
Min: 46.05 Med: 64.19 Max: 74.57
Current: 70.24
During the past 13 years, the highestGross Margin % of Milestone Scientific was 74.57%. The lowest was 46.05%. And the median was 64.19%.
MLSS's Gross Margin % is ranked better than 80.35% of 804
companies
in the Medical Devices & Instruments industry
Industry Median: 52.26
vs MLSS: 70.24
Milestone Scientific had a gross margin of 67.23% for the quarter that ended in Jun. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Milestone Scientific was 3.40% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Milestone Scientific had a gross margin of 67.23% for the quarter that ended in Jun. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Milestone Scientific Gross Margin % Related Terms
Milestone Scientific Gross Margin % Historical Data
* Premium members only.
The historical data trend for Milestone Scientific's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MLSS vs NEPH, HBIO, POCI: Gross Margin % Comparison
For the Medical Instruments & Supplies subindustry, Milestone Scientific's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Milestone Scientific Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Milestone Scientific's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Milestone Scientific's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Milestone Scientific (MLSS) has a Gross Margin % of 67.23% as of Jun. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Milestone Scientific and its competitors. This is near median its historical median of 64.19. Over the past decade, Milestone Scientific's Gross Margin % has ranged from 46.05 to 74.57. According to the industry distribution chart, Milestone Scientific ranks #158 out of 804 companies in the Medical Devices & Instruments industry, placing it in the top 19.7%.
Is Milestone Scientific's Gross Margin % too high?
Milestone Scientific's current Gross Margin % of 67.23% is near median its 10-year median of 64.19. Over the past 10 years, this metric has ranged from a low of 46.05 to a high of 74.57. The Medical Devices & Instruments industry median Gross Margin % is 52.26. Milestone Scientific's value of 67.23% is 28.6% above this industry median. Based on the distribution chart, Milestone Scientific ranks #158 out of 804 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Milestone Scientific has a GF Score™ of 37/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Milestone Scientific's Gross Margin % compare to NEPH and HBIO?
According to the Medical Devices & Instruments industry distribution chart, Milestone Scientific ranks #158 out of 804 companies for Gross Margin %. This places Milestone Scientific in the top 20% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 52.26. Milestone Scientific's value of 67.23% is 28.6% above this benchmark. Historically, Milestone Scientific's own Gross Margin % has ranged from 46.05 to 74.57 over the past decade. While the company's 10-year median is 64.19 vs. the industry median of 52.26, Milestone Scientific has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.26, based on 804 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Milestone Scientific's current Gross Margin % of 67.23% is 28.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Milestone Scientific and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Milestone Scientific's current Gross Margin % is 67.23%, which is near median its own 10-year median of 64.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Milestone Scientific stock overvalued right now?
Based on GuruFocus' analysis, Milestone Scientific (MLSS) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.60, compared to a current price of $0.50 — trading 17.5% below its estimated fair value. The current Gross Margin % is 67.23%, which is near median its 10-year median of 64.19 and 28.6% above the Medical Devices & Instruments industry median of 52.26. Milestone Scientific's overall GF Score™ is 37/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Milestone Scientific (MLSS), the current Gross Margin % is 67.23% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Milestone Scientific (MLSS) Overvalued in 2026?
Based on GuruFocus' analysis, Milestone Scientific stock appears to be undervalued.
The current stock price of $0.50 is trading 17.5% below its estimated GF Value™ of $0.60.
GuruFocus considers Milestone Scientific to be Modestly Undervalued.
Key valuation signals for MLSS:
Gross Margin %: 67.23% (near median its 10-year median of 64.19)
GF Value™: $0.60 vs. price of $0.50 (17.5% below fair value)
Industry Position: 28.6% above the Medical Devices & Instruments median (#158 of 804)
No single metric tells the full story. See the MLSS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.
37GF Score
Get the complete analysis for MLSS
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MLSS has been successfully added to your 
